Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Stricker, Sarah ^a   Oberwahrenbrock, Timm ^b   Zimmermann, Hanna ^b   Schroeter, Jan ^a   Endres, Matthias ^a   Brandt, Alexander U ^b   Paul, Friedemann ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; EYE EXAMINATION; FEMALE; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; NERVE DEGENERATION; OPTIC NERVE; OPTIC NERVE ATROPHY; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA LUTEA; RETINA NERVE CELL; SPINOCEREBELLAR ATAXIA TYPE 1; SPINOCEREBELLAR DEGENERATION; VISUAL ACUITY; ADOLESCENT; BRAIN STEM; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; MIDDLE AGED; NERVE FIBER; PATHOLOGY; PROSPECTIVE STUDY; RETINA;

TOBACCO MOSAIC VIRUS;

ADOLESCENT; ADULT; AGED; BRAIN STEM; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBERS; PROSPECTIVE STUDIES; RETINA; SPINOCEREBELLAR ATAXIAS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; YOUNG ADULT;

EID: 79960899217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023024     Document Type: Article

References (28)

1. Schöls L, Bauer P, Schmidt T, Schulte T, Riess O, (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3: 291-304 doi:10.1016/S1474-4422(04)00737-9.
2. Banfi S, Servadio A, Chung MY, Kwiatkowski TJ, McCall AE, et al. (1994) Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat. Genet 7: 513-520 doi:10.1038/ng0894-513.
3. Kang S, Hong S, (2009) Molecular pathogenesis of spinocerebellar ataxia type 1 disease. Mol. Cells 27: 621-627 doi:10.1007/s10059-009-0095-y.
4. Harding AE, (1982) The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'. Brain 105: 1-28.
5. Miller RC, Tewari A, Miller JA, Garbern J, Van Stavern GP, (2009) Neuro-ophthalmologic features of spinocerebellar ataxia type 7. J Neuroophthalmol 29: 180-186 doi:10.1097/WNO.0b013e3181b1b3f8.
6. Manrique RK, Noval S, Aguilar-Amat MJ, Arpa J, Rosa I, et al. (2009) Ophthalmic features of spinocerebellar ataxia type 7. J Neuroophthalmol 29: 174-179 doi:10.1097/WNO.0b013e3181b2828e.
7. Abe T, Abe K, Tsuda T, Itoyama Y, Tamai M, (2001) Ophthalmological findings in patients with spinocerebellar ataxia type 1 are not correlated with neurological anticipation. Graefes Arch. Clin. Exp. Ophthalmol 239: 722-728.
8. Abe T, Abe K, Aoki M, Itoyama Y, Tamai M, (1997) Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. Arch. Ophthalmol 115: 231-236.
9. Abele M, Bürk K, Andres F, Topka H, Laccone F, et al. (1997) Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain 120 (Pt12): 2141-2148.
10. Perretti A, Santoro L, Lanzillo B, Filla A, De Michele G, et al. (1996) Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients. J. Neurol. Sci 142: 45-53.
11. Robitaille Y, Schut L, Kish SJ, (1995) Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropathol 90: 572-581.
12. van Velthoven MEJ, Faber DJ, Verbraak FD, van Leeuwen TG, de Smet MD, (2007) Recent developments in optical coherence tomography for imaging the retina. Prog Retin Eye Res 26: 57-77 doi:10.1016/j.preteyeres.2006.10.002.
13. Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, et al. (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9: 921-932 doi:10.1016/S1474-4422(10)70168-X.
14. Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, et al. (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134: 518-533 doi:10.1093/brain/awq346.
15. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, et al. (2011) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21: 24-29.
16. Lu Y, Li Z, Zhang X, Ming B, Jia J, et al. (2010) Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci. Lett 480: 69-72 doi:10.1016/j.neulet.2010.06.006.
17. Bock M, Brandt AU, Dörr J, Kraft H, Weinges-Evers N, et al. (2010) Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg 112: 647-652 doi:10.1016/j.clineuro.2010.04.014.
18. Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, et al. (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66: 1717-1720 doi:10.1212/01.wnl.0000219042.60538.92.
19. Mayer MA, Hornegger J, Mardin CY, Tornow RP (o.J.), Retinal Nerve Fiber Layer Segmentation on FD-OCT Scans of Normal Subjects and Glaucoma Patients. Biomed Opt Express 1: 1358-1383 doi:10.1364/BOE.1.001358.
20. Almarcegui C, Dolz I, Pueyo V, Garcia E, Fernandez F, et al. (2010) Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients. Neurophysiologie Clinique/Clinical Neurophysiology 40: 129-135 doi:10.1016/j.neucli.2009.12.001.
21. Carelli V, Ross-Cisneros FN, Sadun AA, (2002) Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem. Int 40: 573-584.
22. Carelli V, Ross-Cisneros FN, Sadun AA, (2004) Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 23: 53-89 doi:10.1016/j.preteyeres.2003.10.003.
23. Kim S, Kim T, Kim IY, Hong S, Rhim H, et al. (2003) Polyglutamine-expanded ataxin-1 recruits Cu/Zn-superoxide dismutase into the nucleus of HeLa cells. Biochem. Biophys. Res. Commun 307: 660-665.
24. Fortuna F, Barboni P, Liguori R, Valentino ML, Savini G, et al. (2009) Visual system involvement in patients with Friedreich's ataxia. Brain 132: 116-123 doi:10.1093/brain/awn269.
25. Gelfand JM, Duncan JL, Racine CA, Gillum LA, Chin CT, et al. (2010) Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol Available: http://www.ncbi.nlm.nih.gov/pubmed/20953793. Zugegriffen 5 Feb 2011.
26. Walia S, Fishman GA, Edward DP, Lindeman M, (2007) Retinal nerve fiber layer defects in RP patients. Invest. Ophthalmol. Vis. Sci 48: 4748-4752 doi:10.1167/iovs.07-0404.
27. McLaughlin ME, Dryja TP, (2002) Ocular findings in spinocerebellar ataxia 7. Arch. Ophthalmol 120: 655-659.
28. La Spada AR, Fu Y, Sopher BL, Libby RT, Wang X, et al. (2001) Polyglutamine-Expanded Ataxin-7 Antagonizes CRX Function and Induces Cone-Rod Dystrophy in a Mouse Model of SCA7. Neuron 31: 913-927 doi:10.1016/S0896-6273(01)00422-6.